Product Code: ETC11393166 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The India antihypertensive drugs market import shipment experienced a slight decline with a negative CAGR from 2020 to 2024. However, there was a notable uptick in growth rate between 2023 and 2024, indicating a potential recovery or market stabilization towards the end of the period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Antihypertensive Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Antihypertensive Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Antihypertensive Drugs Market - Industry Life Cycle |
3.4 India Antihypertensive Drugs Market - Porter's Five Forces |
3.5 India Antihypertensive Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 India Antihypertensive Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 India Antihypertensive Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Antihypertensive Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of hypertension in India due to lifestyle changes, stress, and unhealthy diet. |
4.2.2 Increasing awareness about the risks associated with uncontrolled hypertension and the benefits of early treatment. |
4.2.3 Rising geriatric population in India, who are more susceptible to hypertension and related complications. |
4.3 Market Restraints |
4.3.1 Lack of access to healthcare services in rural areas, limiting the reach of antihypertensive drugs. |
4.3.2 High cost of antihypertensive medications, especially for long-term treatment, affecting affordability for some segments of the population. |
5 India Antihypertensive Drugs Market Trends |
6 India Antihypertensive Drugs Market, By Types |
6.1 India Antihypertensive Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 India Antihypertensive Drugs Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 India Antihypertensive Drugs Market Revenues & Volume, By Beta Blockers, 2021 - 2031F |
6.1.4 India Antihypertensive Drugs Market Revenues & Volume, By ACE Inhibitors, 2021 - 2031F |
6.1.5 India Antihypertensive Drugs Market Revenues & Volume, By Diuretics, 2021 - 2031F |
6.1.6 India Antihypertensive Drugs Market Revenues & Volume, By Calcium Channel Blockers, 2021 - 2031F |
6.2 India Antihypertensive Drugs Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 India Antihypertensive Drugs Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 India Antihypertensive Drugs Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 India Antihypertensive Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 India Antihypertensive Drugs Market Revenues & Volume, By Retail, 2021 - 2031F |
6.3.3 India Antihypertensive Drugs Market Revenues & Volume, By Hospital, 2021 - 2031F |
6.3.4 India Antihypertensive Drugs Market Revenues & Volume, By Online, 2021 - 2031F |
6.3.5 India Antihypertensive Drugs Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
7 India Antihypertensive Drugs Market Import-Export Trade Statistics |
7.1 India Antihypertensive Drugs Market Export to Major Countries |
7.2 India Antihypertensive Drugs Market Imports from Major Countries |
8 India Antihypertensive Drugs Market Key Performance Indicators |
8.1 Average blood pressure control rate among hypertensive patients in India. |
8.2 Number of healthcare facilities offering hypertension screening and treatment services. |
8.3 Percentage increase in the adoption of generic antihypertensive drugs in the market. |
8.4 Patient adherence rate to prescribed antihypertensive medication regimens. |
8.5 Percentage reduction in hypertension-related hospitalizations and complications. |
9 India Antihypertensive Drugs Market - Opportunity Assessment |
9.1 India Antihypertensive Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 India Antihypertensive Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 India Antihypertensive Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Antihypertensive Drugs Market - Competitive Landscape |
10.1 India Antihypertensive Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Antihypertensive Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |